GreenLight Biosciences (the Company or GreenLight Bio), a pioneering agricultural biotechnology company, today announced a ...

DSTL focuses on strong balance sheets, stable cash flows, and attractive valuations. Check out my recommendation for the fund ...

In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between ...

No refractures were reported during long-term follow-up at five yearsAt 24-months post-implantation, 89% of patients achieved bone unionNovadip plans market launch of NVD003 in 2027Mont Saint-Guibert, ...

EA Bridgeway Omni Small-Cap Value ETF offers excellent exposure to the size and value factors. Read why I'm bullish on the ...

The worldwide hyperphosphatemia industry is anticipated to reach a valuation of around USD 12.66 billion in 2023 and grow at a compound annual growth rate (CAGR) of more than 4.8% until 2033. By 2033, ...

A startup out of Finland is taking a new look at the market for prescription eyewear. Tapping into innovations in ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

You might remember the health struggles of the iconic singer Mariah Carey during her pregnancy with twins in 2011. She faced ...

PacBio was the first to detect native epigenetic modifications alongside accurate DNA sequencing. With the integration of the CUHK deep learning models, our technology will be able to detect many ...